Oscar Health (OSCR)
(Delayed Data from NYSE)
$16.35 USD
-0.45 (-2.68%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $16.34 -0.01 (-0.06%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Cash flow Statements
Fiscal Year End for Oscar Health, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -270.59 | -609.55 | -571.43 | -406.83 | -261.18 |
Depreciation/Amortization & Depletion | 2.10 | 18.48 | 22.97 | 14.20 | 0.25 |
Net Change from Assets/Liabilities | -192.09 | 857.99 | 247.70 | 575.70 | 62.21 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 188.42 | 113.44 | 119.02 | 39.66 | 33.36 |
Net Cash From Operating Activities | -272.16 | 380.35 | -181.75 | 222.73 | -165.37 |
Property & Equipment | -25.58 | -29.01 | -25.89 | -14.02 | -26.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 605.04 | -198.62 | -755.31 | -329.45 | 183.59 |
Other Investing Activities | -2.28 | 1.12 | 6.68 | -1.24 | -7.08 |
Net Cash from Investing Activities | 577.19 | -226.52 | -774.52 | -344.71 | 150.51 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 3.96 | 1.30 | 1,407.10 | 469.55 | -2.12 |
Issuance (Repayment) of Debt | 0.00 | 305.00 | -153.17 | 147.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 2.49 | -5.19 | -15.21 | -4.84 | 0.00 |
Net Cash from Financing Activities | 6.45 | 301.11 | 1,238.71 | 611.71 | -2.12 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 311.47 | 454.94 | 282.45 | 489.73 | -16.98 |
Cash at Beginning of Period | 1,580.50 | 1,125.56 | 843.11 | 353.38 | 370.36 |
Cash at End of Period | 1,891.97 | 1,580.50 | 1,125.56 | 843.11 | 353.38 |
Diluted Net EPS | -1.22 | -2.85 | -3.20 | -4.72 | NA |
Fiscal Year End for Oscar Health, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | 233.79 | 177.48 | -270.59 | -120.76 |
Depreciation/Amortization & Depletion | NA | 3.58 | 1.78 | 2.10 | 0.68 |
Net Change from Assets/Liabilities | NA | 840.63 | 430.24 | -192.09 | -582.66 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 53.51 | 24.87 | 188.42 | 133.71 |
Net Cash From Operating Activities | NA | 1,131.51 | 634.36 | -272.16 | -569.03 |
Property & Equipment | NA | -13.51 | -5.95 | -25.58 | -19.48 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | -766.16 | -295.27 | 605.04 | 424.09 |
Other Investing Activities | NA | 1.45 | 0.63 | -2.28 | 0.10 |
Net Cash from Investing Activities | NA | -778.22 | -300.59 | 577.19 | 404.71 |
Uses of Funds
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 46.01 | 27.31 | 3.96 | 2.89 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 2.49 | 2.49 |
Net Cash from Financing Activities | NA | 46.01 | 27.31 | 6.45 | 5.38 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | 399.31 | 361.08 | 311.47 | -158.94 |
Cash at Beginning of Period | NA | 1,891.97 | 1,891.97 | 1,580.50 | 1,580.50 |
Cash at End of Period | NA | 2,291.28 | 2,253.05 | 1,891.97 | 1,421.56 |
Diluted Net EPS | NA | 0.20 | 0.62 | -0.68 | -0.29 |